194 related articles for article (PubMed ID: 12174172)
1. Longitudinal study evaluating neuropsychological changes in so-called asymptomatic carriers of the Huntington's disease mutation after 1 year.
Lemiere J; Decruyenaere M; Evers-Kiebooms G; Vandenbussche E; Dom R
Acta Neurol Scand; 2002 Sep; 106(3):131-41. PubMed ID: 12174172
[TBL] [Abstract][Full Text] [Related]
2. Cognitive changes in patients with Huntington's disease (HD) and asymptomatic carriers of the HD mutation--a longitudinal follow-up study.
Lemiere J; Decruyenaere M; Evers-Kiebooms G; Vandenbussche E; Dom R
J Neurol; 2004 Aug; 251(8):935-42. PubMed ID: 15316797
[TBL] [Abstract][Full Text] [Related]
3. Cognition in Huntington's disease in manifest, premanifest and converting gene carriers over ten years.
Hart EP; Dumas EM; Giltay EJ; Middelkoop HA; Roos RA
J Huntingtons Dis; 2013; 2(2):137-47. PubMed ID: 25063511
[TBL] [Abstract][Full Text] [Related]
4. Postural deficits in Huntington's disease when performing motor skills involved in daily living.
Panzera R; Salomonczyk D; Pirogovosky E; Simmons R; Goldstein J; Corey-Bloom J; Gilbert PE
Gait Posture; 2011 Mar; 33(3):457-61. PubMed ID: 21256027
[TBL] [Abstract][Full Text] [Related]
5. Early cognitive deficits in Swedish gene carriers of Huntington's disease.
Robins Wahlin TB; Lundin A; Dear K
Neuropsychology; 2007 Jan; 21(1):31-44. PubMed ID: 17201528
[TBL] [Abstract][Full Text] [Related]
6. Assessing impairment of executive function and psychomotor speed in premanifest and manifest Huntington's disease gene-expansion carriers.
Unmack Larsen I; Vinther-Jensen T; Gade A; Nielsen JE; Vogel A
J Int Neuropsychol Soc; 2015 Mar; 21(3):193-202. PubMed ID: 25850430
[TBL] [Abstract][Full Text] [Related]
7. Are cognitive changes the first symptoms of Huntington's disease? A study of gene carriers.
Hahn-Barma V; Deweer B; Dürr A; Dodé C; Feingold J; Pillon B; Agid Y; Brice A; Dubois B
J Neurol Neurosurg Psychiatry; 1998 Feb; 64(2):172-7. PubMed ID: 9489526
[TBL] [Abstract][Full Text] [Related]
8. Visual processing disorders in patients with Huntington's disease and asymptomatic carriers.
Gómez-Tortosa E; del Barrio A; Barroso T; García Ruiz PJ
J Neurol; 1996 Mar; 243(3):286-92. PubMed ID: 8936361
[TBL] [Abstract][Full Text] [Related]
9. Cognitive changes in asymptomatic carriers of the Huntington disease mutation gene.
Verny C; Allain P; Prudean A; Malinge MC; Gohier B; Scherer C; Bonneau D; Dubas F; Le Gall D
Eur J Neurol; 2007 Dec; 14(12):1344-50. PubMed ID: 17941857
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal cognitive and motor changes among presymptomatic Huntington disease gene carriers.
Kirkwood SC; Siemers E; Stout JC; Hodes ME; Conneally PM; Christian JC; Foroud T
Arch Neurol; 1999 May; 56(5):563-8. PubMed ID: 10328251
[TBL] [Abstract][Full Text] [Related]
11. Altered frontostriatal coupling in pre-manifest Huntington's disease: effects of increasing cognitive load.
Wolf RC; Sambataro F; Vasic N; Schönfeldt-Lecuona C; Ecker D; Landwehrmeyer B
Eur J Neurol; 2008 Nov; 15(11):1180-90. PubMed ID: 18754766
[TBL] [Abstract][Full Text] [Related]
12. Do I misconstrue? Sarcasm detection, emotion recognition, and theory of mind in Huntington disease.
Larsen IU; Vinther-Jensen T; Gade A; Nielsen JE; Vogel A
Neuropsychology; 2016 Feb; 30(2):181-9. PubMed ID: 26301773
[TBL] [Abstract][Full Text] [Related]
13. HD-CAB: a cognitive assessment battery for clinical trials in Huntington's disease 1,2,3.
Stout JC; Queller S; Baker KN; Cowlishaw S; Sampaio C; Fitzer-Attas C; Borowsky B;
Mov Disord; 2014 Sep; 29(10):1281-8. PubMed ID: 25209258
[TBL] [Abstract][Full Text] [Related]
14. Evidence of presymptomatic cognitive decline in Huntington's disease.
Diamond R; White RF; Myers RH; Mastromauro C; Koroshetz WJ; Butters N; Rothstein DM; Moss MB; Vasterling J
J Clin Exp Neuropsychol; 1992 Nov; 14(6):961-75. PubMed ID: 1452640
[TBL] [Abstract][Full Text] [Related]
15. A double blind evaluation of cognitive decline in a Norwegian cohort of asymptomatic carriers of Huntington's disease.
van Walsem MR; Sundet K; Retterstøl L; Sundseth Ø
J Clin Exp Neuropsychol; 2010 Jul; 32(6):590-8. PubMed ID: 19916101
[TBL] [Abstract][Full Text] [Related]
16. Cognitive Dysfunction Contributes to Mobility Impairments in Huntington's Disease.
Kloos AD; Kegelmeyer DA; Fritz NE; Daley AM; Young GS; Kostyk SK
J Huntingtons Dis; 2017; 6(4):363-370. PubMed ID: 29254103
[TBL] [Abstract][Full Text] [Related]
17. Motor dysfunction influence on executive functioning in manifest and premanifest Huntington's disease.
Hart EP; Dumas EM; Schoonderbeek A; Wolthuis SC; van Zwet EW; Roos RA
Mov Disord; 2014 Mar; 29(3):320-6. PubMed ID: 24500841
[TBL] [Abstract][Full Text] [Related]
18. Cognitive change in patients with Huntington disease on the Repeatable Battery for the Assessment of Neuropsychological Status.
Beglinger LJ; Duff K; Allison J; Theriault D; O'Rourke JJ; Leserman A; Paulsen JS
J Clin Exp Neuropsychol; 2010 Jul; 32(6):573-8. PubMed ID: 19882420
[TBL] [Abstract][Full Text] [Related]
19. Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data.
Tabrizi SJ; Reilmann R; Roos RA; Durr A; Leavitt B; Owen G; Jones R; Johnson H; Craufurd D; Hicks SL; Kennard C; Landwehrmeyer B; Stout JC; Borowsky B; Scahill RI; Frost C; Langbehn DR;
Lancet Neurol; 2012 Jan; 11(1):42-53. PubMed ID: 22137354
[TBL] [Abstract][Full Text] [Related]
20. Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.
Tabrizi SJ; Scahill RI; Owen G; Durr A; Leavitt BR; Roos RA; Borowsky B; Landwehrmeyer B; Frost C; Johnson H; Craufurd D; Reilmann R; Stout JC; Langbehn DR;
Lancet Neurol; 2013 Jul; 12(7):637-49. PubMed ID: 23664844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
